HUM vs STRO
Humana Inc (HUM) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the HUM and STRO stock pages for the full models.
Not investment advice.